The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(1-acryloylpiperidin-3-yl)-4-(2,6-dichlorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate ID: ALA4555583
PubChem CID: 155556700
Max Phase: Preclinical
Molecular Formula: C21H20Cl2F3N5O5
Molecular Weight: 436.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N1CCC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2c(Cl)cccc2Cl)C1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C19H19Cl2N5O3.C2HF3O2/c1-2-15(27)26-8-4-5-11(10-26)23-19(29)17-14(9-22-25-17)24-18(28)16-12(20)6-3-7-13(16)21;3-2(4,5)1(6)7/h2-3,6-7,9,11H,1,4-5,8,10H2,(H,22,25)(H,23,29)(H,24,28);(H,6,7)/t11-;/m0./s1
Standard InChI Key: PXEJTESISIAKFN-MERQFXBCSA-N
Molfile:
RDKit 2D
36 37 0 0 0 0 0 0 0 0999 V2000
19.6972 -12.7947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4049 -12.3861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9895 -12.3861 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.6972 -13.6119 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.9873 -13.1991 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.1126 -12.7947 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4049 -11.5689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8779 -9.7670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4643 -10.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8695 -11.1760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6870 -11.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0978 -10.4727 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6910 -9.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1923 -11.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0095 -11.8823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7837 -11.1746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7837 -12.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9674 -12.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5589 -13.2941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9676 -14.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7890 -14.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1938 -13.2927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5602 -11.8788 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.0110 -13.2893 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.6439 -11.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4181 -11.1768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2353 -11.1746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4858 -10.3967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8233 -9.9180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1635 -10.4002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4611 -11.8823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2353 -12.5900 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9149 -10.4755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3211 -11.1846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3260 -9.7691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1383 -11.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 1 0
1 5 1 0
2 6 1 0
2 7 2 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 1 0
14 16 2 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
22 24 1 0
15 26 1 0
27 25 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 1 0
30 26 2 0
25 31 1 0
25 32 2 0
10 31 1 1
12 33 1 0
33 34 1 0
33 35 2 0
34 36 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 436.30Molecular Weight (Monoisotopic): 435.0865AlogP: 2.88#Rotatable Bonds: 5Polar Surface Area: 107.19Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.75CX Basic pKa: 0.19CX LogP: 3.15CX LogD: 3.15Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.63Np Likeness Score: -1.52
References 1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010 ] [10.1016/j.bmcl.2019.05.024 ]